Sankha Amarakoon

A Genetic Case-Control Study Confirms the Implication of<i>SMAD7</i>and<i>TNF Locus</i>in the Development of Proliferative Vitreoretinopathy

Jimena Rojas, Itziar Fernández, José Carlos Pastor Jimeno et al. · Investigative Ophthalmology & Visual Science · 2012 · 47 citations · Full text

Bevacizumab in age-related macular degeneration: a randomized controlled trial on the effect of injections every 4 weeks, 6 weeks and 8 weeks

Tanya Lushchyk, Sankha Amarakoon, José Martínez-Ciriano et al. · Acta Ophthalmologica · 2013 · 31 citations · Full text

Predicting proliferative vitreoretinopathy: temporal and external validation of models based on genetic and clinical variables

Jimena Rojas, Itziar Fernández, José Carlos Pastor Jimeno et al. · British Journal of Ophthalmology · 2014 · 23 citations · Full text

Bevacizumab in age‐related macular degeneration: a randomized controlled trial on the effect of on‐demand therapy every 4 or 8 weeks

Sankha Amarakoon, José P. Martinez Ciriano, L. Ingeborgh van den Born et al. · Acta Ophthalmologica · 2018 · 15 citations · Full text

Prospective, Randomized Intervention Study Comparing Retinal Pigment Epithelium-Choroid Graft Surgery and Anti-VEGF Therapy in Patients with Exudative Age-Related Macular Degeneration

Elsbeth J. T. van Zeeburg, Matteo Giuseppe Cereda, Sankha Amarakoon et al. · Ophthalmologica · 2015 · 14 citations